Myocardial dysfunction in sepsis

Critical Care Clinics

Volumn 5, Issue 1, 1989, Pages 99-118

  Cunnion, R E ^a   Parrillo, J E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

BIOCHEMISTRY; CORONARY ARTERY BLOOD FLOW; HEART FUNCTION; HEMODYNAMIC MONITORING; HUMAN; HYPERTHERMIA; NONHUMAN; REVIEW; SEPSIS; SHOCK;

EID: 0024579680     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0749-0704(18)30452-4     Document Type: Review

References (44)

1. Adiseshiah M. Baird R.J. Correlation of the changes in diastolic myocardial tissue pressure and regional coronary blood flow in hemorrhagic and endotoxic shock J Surg Res 24 1978 20
2. Brenner M. Doerfler M.E. Danner R.L. Determination of direct myocardial contractile effects of eicosanoids, endotoxin, tumor necrosis factor and other mediators using a newly designed quantitative cellular contractility assay Clin Res 35 1987 785A
3. Breslow M.J. Miller C.F. Parker S. Effect of catecholamines on organ blood flow during endotoxin shock in the pig Crit Care Med 12 1984 246
4. Calvin J.E. Driedger A.A. Sibbald W.J. An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy Chest 38 1981 579
5. Clowes G.H. Farrington G.H. Zuschneid W. Circulating factors in the etiology of pulmonary insufficiency and right heart failure accompanying severe sepsis (peritonitis) Ann Surg 171 1970 663
6. Cunnion R.E. Schaer G.L. Parker M.M. The coronary circulation in human septic shock Circulation 73 1986 637
7. Danner R.L. Elin R.J. Hosseini J.M. Endotoxin determinations in 100 patients with septic shock Clin Res 36 1988 453A
8. Dhainaut J.-F. Huyghebaert M.-F. Monsallier J.F. Coronary hemodynamics and myo cardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock Circulation 75 1987 533
9. Eichenholz P.W. Natanson C. Eichacker P.Q. Hemodynamic effects of tumor necrosis factor infusions in conscious dogs Crit Care Med 16 1988 415
10. Ellrodt A.G. Riedinger M.S. Kimchi A. Left ventricular performance in septic shock: Reversible segmental and global abnormalities Am Heart J 110 1985 402
11. Greene L.J. Shapanka R. Glenn T.M. Isolation of myocardial depressant factor from plasma of dogs in hemorrhagic shock Biochem Biophys Acta 491 1977 275
12. Harris P.J. Harrel F.E. Lee K.L. Survival in medically treated coronary artery disease Circulation 60 1979 1259
13. Hinshaw L.B. Archer L.T. Spitzer J.J. Effects of coronary hypotension and endotoxin on myocardial performance Am J Physiol 227 1974 1051
14. Hinshaw L.B. Myocardial function in endotoxin shock Circ Shock 1 suppl 1979 43
15. Kimchi A. Ellrodt A.G. Berman D.S. Right ventricular performance in septic shock: A combined radionuclide and hemodynamic study J Am Goll Cardiol 4 1984 945
16. Lefer A.M. Mechanisms of cardiodepression in endotoxin shock Circ Shock 1 suppl 1979 1
17. Lefer A.M. Role of a myocardial depressant factor in the pathogenesis of circulatory shock Fed Proc 29 1970 1836
18. MacLean L.D. Mulligan W.G. McLean A.P.H. Patterns of septic shock in man—A detailed study of 56 patients Ann Surg 166 1967 543
19. Natanson C. Cunnion R.E. Barrett D.A. Reversible myocardial dysfunction in a canine model of septic shock is associated with myocardial microcirculatory damage and focal neutrophil infiltration Clin Res 34 1986 639A
20. Natanson C. Danner R.L. Fink M.P. Cardiovascular performance with E. coli challenges in a canine model of human sepsis Am J Physiol 254 1988 H558 (Heart Circ Physiol 23)
21. Natanson C. Danner R.L. MacVittie Endotoxin administration to dogs simulates the cardiovascular profile of human septic shock Clin Res 35 1987 385A
22. Natanson C, Danner RL, Elin RJ, et al: The role of endotoxemia in cardiovascular dys function and mortality; E. coli and S. aureus challenges in a canine model of human septic shock. J Clin Invest, in press
23. Natanson C. Fink M.P. Ballantyne H.K. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock J Clin Invest 78 1986 259
24. Nishijima H. Weil M.H. Lubin H.S. Hemodynamic and metabolic studies on shock associated with gram-negative bacteremia Medicine (Baltimore) 52 1973 287
25. Ognibene F.P. Parker M.M. Burch-Whitman C. Neutrophil aggregating activity and septic shock in humans: Neutrophil aggregation by a C5a-like material occurs more frequently than complement component depletion and correlates with depression of systemic vascular resistance J Crit Care 3 1988 103
26. Ognibene F.P. Parker M.M. Natanson C. Depressed left ventricular performance: Response to volume infusion in patients with sepsis and septic shock Chest 93 1988 903
27. Ognibene F.P. Rosenberg S.A. Lotze M. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction which are similar to those seen in septic shock Chest 94 1988 750
28. Parker M.M. McCarthy K.E. Ognibene F.P. Similar patterns of left and right ventricular dysfunction in survivors and nonsurvivors of septic shock in humans Crit Care Med 16 1988 393
29. Parker M.M. Shelhamer J.H. Bacharach S.L. Profound but reversible myocardial depression in patients with septic shock Ann Intern Med 100 1984 483
30. Parker M.M. Shelhamer J.H. Natanson C. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis Crit Care Med 15 1987 923
31. Parker M.M. Shelhamer J.H. Ognibene F.P. Pneumocystis pneumonia and bacterial pneumonia produce similar hemodynamic abnormalities Clin Res 32 1984 252A
32. Parker M.M. Suffredini A.F. Natanson C. Survivors of septic shock in humans develop reversible myocardial depression and ventricular dilatation Clin Res 34 1986 413A
33. Parrillo J.E. Burch C. Shelhamer J.H. A circulating myocardial depressant substance in humans with septic shock: Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance J Clin Invest 76 1985 1539
34. Rackow E.C. Kaufman B.S. Falk J.L. Hemodynamic response to fluid repletion in patients with septic shock: Evidence for early depression of cardiac performance Circ Shock 22 1987 11
35. Reilly J.M. Burch-Whitman C. Parker M.M. Characteristics of a myocardial depressant substance in patients with septic shock Circulation 76 suppl IV 1987 164
36. Shapiro R. Breslow M.J. Miller C. Sepsis induced coronary vasodilation Circ Shock 16 1985 79
37. Suffredini A.F. Parker M.M. Brenner M. The cardiovascular effects of intravenous endotoxin in normal human volunteers Crit Care Med 15 1987 439
38. Udhoji V.N. Weil M.H. Hemodynamic and metabolic studies on shock associated with bacteremia Ann Intern Med 62 1965 966
39. Waisbren B.A. Bacteremia due to gram-negative bacilli other than the salmonella Arch Intern Med 88 1951 467
40. Weil M.H. MacLean L.D. Visscher M.B. Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms J Clin Invest 35 1956 1191
41. Weisel R.D. Vito L. Dennis R.C. Myocardial depression during sepsis Am J Surg 133 1977 512
42. Wiles J.B. Cerra F.B. Siegel J.R. The systemic septic response: Does the organism matter? Crit Care Med 8 1980 55
43. Wilson R.F. Thal A.P. Kindling P.J.H. Hemodynamic measurements in septic shock Arch Surg 91 1965 121
44. Winslow E.J. Loeb H.S. Rahimtoola S.H. Hemodynamic studies and results of therapy in 50 patients with bacteremic shock Am J Med 54 1973 421